DNA Investment JSC Income Statement

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	29,051	33,191	47,137	52,358
Revenue Growth (YoY)	-41.09%	-29.59%	-9.97%	-
Cost of Revenue	27,130	30,710	41,333	50,417
Gross Profit	1,921	2,480	5,804	1,941
Selling, General & Admin	3,903	4,092	5,839	4,599
Operating Expenses	3,903	4,092	5,839	4,599
Operating Income	-1,983	-1,612	-35.71	-2,658
Interest Expense	-114.35	-119.86	-132.37	-449.77
Interest & Investment Income	1,326	1,402	438.48	515.28
Currency Exchange Gain (Loss)	948.45	951.89	870.38	325.52
Other Non Operating Income (Expenses)	-679.51	74.37	-57.5	529.41
EBT Excluding Unusual Items	-502.52	696.93	1,083	-1,738
Gain (Loss) on Sale of Assets	-125.54	-125.54	-1,625	1,906
Pretax Income	-628.06	571.4	-541.85	167.75
Income Tax Expense	44.72	44.72	171.73	13.39
Net Income	-672.78	526.67	-713.59	154.36
Net Income to Common	-672.78	526.67	-713.59	154.36
Shares Outstanding (Basic)	12	12	12	12
Shares Outstanding (Diluted)	12	12	12	12
EPS (Basic)	-56.07	43.89	-59.47	12.86
EPS (Diluted)	-56.07	43.89	-59.47	12.86
Free Cash Flow	-12,620	-6,723	5,386	9,138
Free Cash Flow Per Share	-1051.69	-560.25	448.85	761.52
Gross Margin	6.61%	7.47%	12.31%	3.71%
Operating Margin	-6.83%	-4.86%	-0.08%	-5.08%
Profit Margin	-2.32%	1.59%	-1.51%	0.29%
Free Cash Flow Margin	-43.44%	-20.26%	11.43%	17.45%
EBITDA	1,468	1,921	4,458	-2,169
EBITDA Margin	5.05%	5.79%	9.46%	-4.14%
D&A For EBITDA	3,451	3,532	4,494	489.91
EBIT	-1,983	-1,612	-35.71	-2,658
EBIT Margin	-6.83%	-4.86%	-0.08%	-5.08%
Effective Tax Rate	-	7.83%	-	7.98%
Revenue as Reported	29,051	33,191	47,137	52,358